Trials / Completed
CompletedNCT01806792
Post-menopausal Women Osteoporosis(Phase III)
For 4 Months, the Multi Center, Double Blinded, Randomized, Active Controlled, Comparative Clinical Study to Assess the Efficacy and the Safety to Improvement Effect of Vit.D of Risenex Plus M Tablet in Patients With In Post-menopausal Women Osteoporosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and the safety of Risedronate, cholecalciferol combination tablet in patients with Osteoporosis
Detailed description
The purpose of this study is to evaluate the efficacy and the safety of Monthly Risedronate with cholecalciferol on 25 Hydroxyvitamin D level and bone markers patients with osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | risedronate combine | |
| DRUG | Risedronate | |
| DRUG | Placebo(for Risedronate) | |
| DRUG | Placebo(for risedronate combine) |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-08-01
- Completion
- 2011-03-01
- First posted
- 2013-03-07
- Last updated
- 2013-03-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01806792. Inclusion in this directory is not an endorsement.